CANADA LIFE ASSURANCE Co - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
-54.5%
4,6350.0%0.00%
Q2 2023$11
-91.6%
4,635
-91.4%
0.00%
Q1 2023$131
+1355.6%
54,172
+1068.8%
0.00%
Q4 2022$9
-100.0%
4,635
-87.6%
0.00%
Q3 2022$89,000
+888.9%
37,343
+705.7%
0.00%
Q2 2022$9,000
-10.0%
4,6350.0%0.00%
Q1 2022$10,000
-44.4%
4,6350.0%0.00%
Q4 2021$18,000
+125.0%
4,635
+10.6%
0.00%
Q1 2020$8,000
-52.9%
4,1920.0%0.00%
Q4 2019$17,000
+30.8%
4,1920.0%0.00%
Q3 2019$13,000
-74.0%
4,192
-46.9%
0.00%
Q2 2019$50,000
+13.6%
7,9000.0%0.00%
Q1 2019$44,000
-13.7%
7,9000.0%0.00%
Q4 2018$51,000
-39.3%
7,9000.0%0.00%
Q3 2018$84,000
-11.6%
7,9000.0%0.00%
Q2 2018$95,000
+39.7%
7,9000.0%0.00%
Q1 2018$68,000
-12.8%
7,9000.0%0.00%
Q4 2017$78,000
-19.6%
7,9000.0%0.00%
Q3 2017$97,000
-25.4%
7,9000.0%0.00%
Q2 2017$130,000
+15.0%
7,9000.0%0.00%
Q1 2017$113,000
+2.7%
7,9000.0%0.00%
Q4 2016$110,000
-61.3%
7,900
-50.0%
0.00%
Q3 2016$284,000
+151.3%
15,800
+100.0%
0.00%
Q2 2016$113,000
+20.2%
7,9000.0%0.00%
Q1 2016$94,000
-10.5%
7,9000.0%0.00%
Q4 2015$105,000
+23.5%
7,9000.0%0.00%
Q3 2015$85,000
+8400.0%
7,900
+6024.0%
0.00%
Q2 2015$1,0001290.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders